Fact Sheet: President Donald J. Trump Announces Second Deal to Bring Most-Favored-Nation Pricing to American Patients
Fact sheetPublished 25/10/10Open the original
Summary
President Trump announces a second most-favored-nation pricing agreement, with AstraZeneca, giving every state Medicaid program MFN prices on its products; AstraZeneca will invest $50 billion in U.S. manufacturing and R&D by 2030 and create 3,600 jobs at a new Virginia facility.
By industry
- Healthcare & Drug Pricing1 trading day+2.4%p15 stocks5 trading days+0.1%p15 stocks20 trading days+1.9%p15 stocks
“announced the second agreement with a major pharmaceutical company, AstraZeneca”
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 25/10/09 | 0.0% | 0.0% |
| 25/10/10 | −0.9% | −3.3% |
| 25/10/13 | −1.1% | −1.2% |
| 25/10/14 | −0.8% | −1.3% |
| 25/10/15 | −0.7% | −0.8% |
| 25/10/16 | −1.6% | −1.6% |
| 25/10/17 | −0.1% | −0.9% |
| 25/10/20 | +0.8% | +0.1% |
| 25/10/21 | +1.0% | +0.1% |
| 25/10/22 | +0.7% | −0.5% |
| 25/10/23 | +0.3% | +0.1% |
| 25/10/24 | +0.6% | +0.9% |
| 25/10/27 | +1.0% | +2.2% |
| 25/10/28 | +0.3% | +2.4% |
| 25/10/29 | −0.5% | +2.3% |
| 25/10/30 | −0.5% | +2.0% |
| 25/10/31 | −0.3% | +1.6% |
| 25/11/03 | −0.2% | +1.7% |
| 25/11/04 | +0.6% | +0.6% |
| 25/11/05 | +1.7% | +1.1% |
| 25/11/06 | +2.1% | +0.1% |
Stocks it names
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- David Cordani
BuyCigna Group
BuyCigna Group
CI
$999.9K
4,134 sh
$999.9K
Filed 25/11/03
Traded 25/11/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$170.6M
197,814 sh
$170.6M
Filed 25/11/03
Traded 25/10/31
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$83M
101,112 sh
$83M
Filed 25/10/03
Traded 25/10/02
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$69.1M
90,501 sh
$69.1M
Filed 25/10/01
Traded 25/09/30
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$54.2M
63,849 sh
$54.2M
Filed 25/10/07
Traded 25/10/06
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$46.8M
54,191 sh
$46.8M
Filed 25/11/03
Traded 25/10/31
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$30.7M
36,114 sh
$30.7M
Filed 25/10/09
Traded 25/10/08
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$30.4M
39,863 sh
$30.4M
Filed 25/09/19
Traded 25/09/18
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$28.7M
31,016 sh
$28.7M
Filed 25/11/06
Traded 25/11/05
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$26.6M
29,709 sh
$26.6M
Filed 25/11/04
Traded 25/11/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$26.1M
31,102 sh
$26.1M
Filed 25/10/06
Traded 25/10/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$23.8M
28,063 sh
$23.8M
Filed 25/10/07
Traded 25/10/06
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$23.3M
26,340 sh
$23.3M
Filed 25/11/04
Traded 25/11/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$22.8M
25,996 sh
$22.8M
Filed 25/11/04
Traded 25/11/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$22.7M
26,795 sh
$22.7M
Filed 25/10/08
Traded 25/10/07
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$21.5M
25,296 sh
$21.5M
Filed 25/10/09
Traded 25/10/08
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$20.6M
24,495 sh
$20.6M
Filed 25/10/06
Traded 25/10/03
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$20.4M
26,647 sh
$20.4M
Filed 25/09/19
Traded 25/09/18
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$19.5M
22,960 sh
$19.5M
Filed 25/10/07
Traded 25/10/06
- Lilly Endowment
SellELI Lilly
SellELI Lilly
LLY
$19.4M
21,884 sh
$19.4M
Filed 25/11/04
Traded 25/11/03